SN6
SHORT NOTE
5M
Describe systemic sclerosis with its types, pathogenesis and organ involvement.
Definition
Systemic sclerosis (scleroderma) is a chronic autoimmune disease characterised by excessive fibrosis of skin and internal organs, widespread small-vessel disease, and autoantibodies.
- Female to male ratio 3:1; peak in the fourth and fifth decades
Classification
| Feature | Limited cutaneous (crest) | Diffuse cutaneous |
|---|---|---|
| Skin involvement | Distal to elbows and knees, plus the face | Proximal limbs and trunk as well |
| Raynaud phenomenon | Precedes by years | Onset close to the skin changes |
| Antibody | Anti-centromere | Anti-Scl-70 (topoisomerase I); anti-RNA polymerase III |
| Visceral disease | Late; pulmonary hypertension | Early and severe; pulmonary fibrosis, renal crisis |
| Prognosis | Better | Worse |
- Crest — Calcinosis, Raynaud phenomenon, Esophageal dysmotility, Sclerodactyly, Telangiectasia
Pathogenesis
An unknown trigger causes endothelial injury in small vessels → Intimal proliferation and vessel narrowing → chronic ischaemia → Immune activation — T cells and macrophages release cytokines → TGF-beta and PDGF stimulate fibroblasts → Excessive collagen deposition in skin and organs → Progressive fibrosis with vascular obliteration
- Three processes act together — vascular damage, autoimmunity and fibrosis; which of them starts the disease is still unknown
Organ Involvement
| Organ | Features |
|---|---|
| Skin | Oedematous then indurated then atrophic; sclerodactyly with tapering fingers; mask-like face with a pinched nose and restricted mouth opening; calcinosis; digital ulcers and pitting scars |
| Vascular | Raynaud phenomenon in over 95% — the usual first symptom, with the triphasic white-blue-red colour change |
| Gastrointestinal (90%) | Oesophageal dysmotility with reflux and stricture; the commonest visceral involvement; bacterial overgrowth and malabsorption; wide-mouthed colonic diverticula |
| Lung | Interstitial fibrosis and pulmonary hypertension — now the leading cause of death |
| Kidney | Scleroderma renal crisis — malignant hypertension with rapidly progressive renal failure; "onion-skin" intimal thickening |
| Heart | Myocardial fibrosis, arrhythmia, pericarditis |
| Musculoskeletal | Arthralgia, tendon friction rubs, myopathy |
CLINICAL PEARL
- Scleroderma renal crisis was once the commonest cause of death and is now largely treatable.
- ACE inhibitors transformed it — and they must be given even when the creatinine is rising, which feels counterintuitive.
- Corticosteroids in high dose precipitate it and are therefore avoided in diffuse disease.
Applied Aspects
- Nailfold capillaroscopy shows dilated and dropped-out capillaries, and distinguishes primary from secondary Raynaud phenomenon early
- Raynaud phenomenon with abnormal capillaroscopy and a positive ANA predicts progression to a connective tissue disease
- Annual screening for pulmonary hypertension and interstitial lung disease with echocardiography and lung function is now standard, since early treatment helps
- Treatment is largely organ-directed — proton pump inhibitors for reflux, calcium channel blockers for Raynaud, ACE inhibitors for renal crisis, immunosuppression for lung fibrosis
- Localised scleroderma (morphoea) affects skin only, has no Raynaud phenomenon or visceral disease, and carries a good prognosis — it must not be confused with the systemic form
All questions in Immunopathology
- Q1Classify hypersensitivity reactions. Describe the mechanism of each type with examples. ★
- Q2Describe the aetiopathogenesis, autoantibodies and morphology of systemic lupus erythematosus. ★
- Q3Describe the pathogenesis and natural history of HIV infection. Add a note on the opportunistic infections and tumours of AIDS. ★
- Q4Describe the types and mechanisms of transplant rejection. Add a note on graft-versus-host disease. ★
- Q5Classify immunodeficiency disorders. Describe the important primary immunodeficiencies and the causes of secondary immunodeficiency. ★
- SN1Describe anaphylaxis with its causes, mechanism and management. ★
- SN2Describe the important autoantibodies with their disease associations. ★
- SN3Describe the HLA system with its classes and functions. Add a note on its disease associations. ★
- SN4Describe the pathogenesis and morphology of rheumatoid arthritis. ★
- SN5Describe immunological tolerance and the mechanisms by which it is lost. ★
- SN6Describe systemic sclerosis with its types, pathogenesis and organ involvement.
- SN7Describe graft-versus-host disease with its requirements, features and prevention.